Literature DB >> 11478786

Lecithinized Cu, Zn-superoxide dismutase limits the infarct size following ischemia-reperfusion injury in rat hearts in vivo.

M Hangaishi1, H Nakajima, J Taguchi , R Igarashi, J Hoshino, K Kurokawa, S Kimura, R Nagai, M Ohno.   

Abstract

Covalent binding of 4 molecules of phosphatidylcholine palmitoyl to human recombinant superoxide dismutase (SOD) results in a compound (lecithinized SOD) that has a longer half-life and greater affinity to the cell membrane than unmodified SOD. We investigated whether lecithinized SOD played a protective role against myocardial ischemia-reperfusion injuries in rats. Rats underwent 45 min of myocardial ischemia by occluding the left coronary artery followed by 120 min of reperfusion. They were randomly assigned to receive either lecithinized SOD, polyethylene glycol conjugated SOD (PEG-SOD), unmodified SOD, free lecithin derivative, or PBS intravenously at 5 min prior to reperfusion. Myocardial infarct area assessed by TTC staining was smaller in lecithinized SOD group than PEG-SOD, unmodified SOD, free lecithin derivative or control group. Blood pressure and heart rate was similar in each group. ELISA demonstrated SOD level in the heart was significantly high in lecithinized SOD group, especially in the heart of ischemia at risk. Although serum SOD level of PEG-SOD was as high as lecithinized SOD, SOD level of the heart was low. These data suggested lecithinized SOD had a protective effect in myocardial ischemia-reperfusion injuries through its increased bioavailability. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478786     DOI: 10.1006/bbrc.2001.5319

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man.

Authors:  F J F Broeyer; B E van Aken; J Suzuki; M J B Kemme; H C Schoemaker; A F Cohen; Y Mizushima; J Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

2.  Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients.

Authors:  Frederik J F Broeyer; Susanne Osanto; Jun Suzuki; Felix de Jongh; Henk van Slooten; Bea C Tanis; Tobias Bruning; Jeroen J Bax; Henk J Ritsema van Eck; Marieke L de Kam; Adam F Cohen; Yutaka Mituzhima; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

3.  Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury.

Authors:  Haekyung Lee; Eun Hee Ko; Mark Lai; Na Wei; Javi Balroop; Zerin Kashem; Ming Zhang
Journal:  Mol Immunol       Date:  2013-12-22       Impact factor: 4.407

4.  Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes.

Authors:  Masahiro Yamawaki; Norihito Sasaki; Masaki Shimoyama; Junichiro Miake; Kazuhide Ogino; Osamu Igawa; Fumito Tajima; Chiaki Shigemasa; Ichiro Hisatome
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 5.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

6.  Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion.

Authors:  Pradeepkumar Charlagorla; Junying Liu; Monaliben Patel; Julie I Rushbrook; Ming Zhang
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

7.  Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo.

Authors:  Emanuela Masini; Salvatore Cuzzocrea; Emanuela Mazzon; Cosimo Marzocca; Pier Francesco Mannaioni; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 8.  Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?

Authors:  Ilaria Farella; Raffaella Panza; Manuela Capozza; Nicola Laforgia
Journal:  Biomed Pharmacother       Date:  2021-07-14       Impact factor: 6.529

9.  Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion.

Authors:  Katarzyna Szadujkis-Szadurska; Grzegorz Grzesk; Leszek Szadujkis-Szadurski; Marta Gajdus; Grzegorz Matusiak
Journal:  Exp Ther Med       Date:  2012-11-30       Impact factor: 2.447

10.  A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis.

Authors:  Y Suzuki; T Matsumoto; S Okamoto; T Hibi
Journal:  Colorectal Dis       Date:  2008-02-21       Impact factor: 3.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.